Home > Blog > Bi-Weekly Newsletter: 12.04.2020

Bi-Weekly Newsletter: 12.04.2020


Year-end sale is on now!

We are so thankful you have chosen InVivo Biosystems to be a partner and trusted us with helping you further your research. As a way of thanks, we are excited to announce our annual end of year sale for 2020!

Purchase a product or C. elegans service from us before December 31st, 2020 and receive 10% off your total purchase*. Use the code endofyear10 at checkout or talk to your sales rep to receive this discount.

One of our scientists takes a deep dive to compare two popular genome editing technologies, CRISPR/Cas9 and Tol2. Learn more about each tool and the pros and cons of each.

For episode 31 of 17 Minutes of Science, we were joined by Dr. Judith Eisen of the University of Oregon to discuss how she has helped to pioneer the use of zebrafish as a model organism throughout her career.

This visual quick-guide offers a look inside the control possible through CRISPR genome edited transgenics, and will offer guidance as to which method would be preferred for your project.

The InVivo Biosystem ScreenChip platform was developed for C. elegans, However, C. elegans represents only one of the estimated 1 million members of the highly diverse phylum Nematoda, of which only ~25,000 species have been described. To demonstrate the utility of microfluidic EPG recordings from species beyond C. elegans, we adapted the platform to record from human and animal parasites, male and female members of a dioecious species, and a carnivorous nematode.

Sign up so you never miss a newsletter

About The Author

InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.

Share this articles

InVivo Biosystems

About the Author:

Connect with us

Table of Contents